Conclusion: This study further supports that nattokinase can be used as an effective adjunctive therapy for hypertension, but relatively low-dose supplementation of nattokinase may have no significant lipid-lowering effect. More work will need to be done to determine whether the positive efficacy of nattokinase on cardiovascular risk factors is dose-dependent.
PubMed 39076715 ↗Nattokinase
The short answer. There isn't much data on Nattokinase yet — 43 mentions, 9 with a clear outcome — so treat these numbers as anecdotal. It is most often used for heart & lipids: 100% of 7 reports say that improved. There is a moderate body of research — 2 meta-analyses and 8 trials.
From 43 mentions in total — the rest didn't say how it went and aren't counted.
What Nattokinase does, according to users
Of the people who reported each effect, the share who said it got better.
3 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
At least one meta-analysis, or 5+ randomized controlled trials. The grade measures how much human research exists — read the conclusions below for what it found. 2 meta-analyses on PubMed ↗ · 8 randomized trials ↗
Conclusion: Together, such efforts support the objectives of the COST Action PIMENTO (CA20128) in building a more robust evidence base on fermented foods and health. The protocol for this systematic review was registered with the Open Science Framework (OSF; registration ID: vg7f6; https://osf.io/vg7f6).
PubMed 41256929 ↗11 human trials on ClinicalTrials.gov test Nattokinase — 7 completed, 2 recruiting now. See all on ClinicalTrials.gov ↗
- Hormone Estradiol Replacement Therapy Additional Herbals · Menopause · 2015
- Nattokinase Atherothrombotic Prevention Study · Prevention of Subclinical Atherosclerosis Progression, Prevention of Cognitive Decline · 2019
- Nattokinase Supplementation and Hemostatic Factors · Hypercholesterolemia · 2016
Reports to the FDA
Adverse-event reports about supplements containing it, submitted to the US FDA by consumers and doctors.
13 reports name a product containing Nattokinase (2004–2025); 10 involved hospitalization or worse. Most often reported:
- Dyspnoea · 3
- Transient ischaemic attack · 2
- Cerebrovascular accident · 2
- Hospitalisation · 2
- Pulmonary embolism · 2
- Hypersensitivity · 2
A report doesn't prove the supplement caused the problem — many products contain several ingredients, and these counts can't tell you how often it happens. Source: FDA CAERS ↗ · raw reports (openFDA) ↗.
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“Nattokinase is known for reducing blood clotting and blood pressure. 'Doctors Best Natto-Serra' helped to lower my hemoglobin from 52 to 44.”
“Natto took about 3 months for me to start seeing the benefits from it. It definitely helps.”
“The best thing that instantly works is nattokinase. I've been in it for 45 days and it's the best my BP has been in 5 years.”
“my Dr told me to try Nattokinase. Took 17 days for the 'ahh, somethings wrong' feeling to lift. Took it for 30 days total”
Nattokinase compared
Other options for heart & lipids
Sources
- User reports: 43 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- US Food and Drug Administration: CAERS adverse-event reports ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate